Welcome to the Thompson Lab!
Our Science
Pancreatic beta cells (green) undergoing a DNA damage response (red) and being attacked by self-reactive immune cells (blue cells surrounding beta cells) in a mouse model for Type 1 Diabetes.
Our lab uses cutting edge approaches to investigate how and why pancreatic beta cells are destroyed in Type 1 Diabetes.
|
Our Location
We are located in the Children's Hospital Research Institute of Manitoba (CHRIM), at the Bannatyne Campus of the University of Manitoba.
|
Recent news from the lab.
Sept 2021. Jasmine joins the lab as a postbac student in PHGY5012 and first student in the lab. Welcome Jasmine!
August 2021. The lab was awarded an Operating Grant from the Children's Hospital Research Institute of Manitoba (CHRIM) for a project to develop a therapy targeting sick human beta cells in Type 1 diabetes! See the press release here.
March 2021. The lab was awarded a grant from the Manitoba Medical Services Foundation (MMSF) for a project to develop a new drug delivery technology to target beta cells. See the press release here.
Sept 2020. The lab officially launches after the COVID-19 closures of summer 2020 and Gabriel joins the lab as the research technician and manager. Welcome Gabriel!
August 2021. The lab was awarded an Operating Grant from the Children's Hospital Research Institute of Manitoba (CHRIM) for a project to develop a therapy targeting sick human beta cells in Type 1 diabetes! See the press release here.
March 2021. The lab was awarded a grant from the Manitoba Medical Services Foundation (MMSF) for a project to develop a new drug delivery technology to target beta cells. See the press release here.
Sept 2020. The lab officially launches after the COVID-19 closures of summer 2020 and Gabriel joins the lab as the research technician and manager. Welcome Gabriel!
PARTNERS
|
|
|
THOMPSON LAB 2020.
